SRS Capital Advisors »

Alaunos Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Alaunos Therapeutics (TCRT) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Alaunos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.7k 1.2k 2.26

More positions owned by SRS Capital Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Comfort Systems USA (FIX)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Index Fds Value Etf (VTV)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for SRS Capital Advisors

Top funds holding Alaunos Therapeutics

BlackRock
Geode Capital Management
Vanguard Fiduciary Trust
Vanguard Capital Management
Citadel Advisors
Advisor Group Holdings
Tower Research Capital
SRS Capital Advisors
UBS Group
Morgan Stanley
Vanguard Global Advisers
Wells Fargo & Company
Royal Bank of Canada
Ronald Blue Trust
Steward Partners Investment Advisory

View all funds holding Alaunos Therapeutics